113 related articles for article (PubMed ID: 34159751)
1. Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components.
Jeon I; Moon SJ; Park SI; Choi Y; Jung J; Yu KS; Chung JY
Clin Pharmacol Drug Dev; 2022 Jan; 11(1):91-99. PubMed ID: 34159751
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects.
Jung J; Lee S; Oh J; Lee S; Jang IJ; Lee D; Yu KS
Transl Clin Pharmacol; 2021 Mar; 29(1):53-64. PubMed ID: 33855001
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects.
Yang E; Lee S; Lee H; Hwang I; Jang IJ; Yu KS; Lee S
Transl Clin Pharmacol; 2019 Dec; 27(4):134-140. PubMed ID: 32095481
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
Choi HY; Kim YH; Kim MJ; Noh YH; Lee SH; Bae KS; Lim HS
Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
.
Park JS; Jeon JY; Kim MG
Int J Clin Pharmacol Ther; 2019 Dec; 57(12):612-622. PubMed ID: 31549624
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants.
Park JW; Chung H; Kim JM; Kim NY; Hong SH; Kim KA; Park JY
Drugs R D; 2024 May; ():. PubMed ID: 38775910
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study.
Son M; Guk J; Kim Y; Woo Chae D; Heo YA; Soh D; Park K
Clin Ther; 2016 Aug; 38(8):1845-57. PubMed ID: 27422590
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
Hu C; Hu X; Wang C; Zhao Z; Gao D; Chen X; Zhou D; Huang Y; Li L; Zhang L
Clin Drug Investig; 2018 Dec; 38(12):1145-1154. PubMed ID: 30232699
[TBL] [Abstract][Full Text] [Related]
14. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.
Lee HW; Kang WY; Jung W; Gwon MR; Yang DH; Kim EH; Cho K; Yoon YR; Seong SJ
Transl Clin Pharmacol; 2020 Jun; 28(2):92-101. PubMed ID: 32656160
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of a fixed-dose combination of metoprolol extended release/amlodipine in patients with mild-to-moderate hypertension: a randomized, parallel-group, multicentre comparison with losartan plus amlodipine.
Pareek A; Chandurkar NB; Sharma R; Tiwari D; Gupta BS
Clin Drug Investig; 2010; 30(2):123-31. PubMed ID: 20067330
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study.
Kim S; Ko JW; Kim JR
Clin Pharmacol Drug Dev; 2020 Apr; 9(3):386-394. PubMed ID: 31373174
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
[TBL] [Abstract][Full Text] [Related]
19. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
20. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
